CoChat

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria

Open access

Published version of a preprint

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

The cell envelope of Mycobacterium tuberculosis , the bacterium that causes the disease tuberculosis, is a complex structure composed of abundant lipids and glycolipids, including the signature lipid of these bacteria, mycolic acids. In this study, we identified two new components of the transport machinery that constructs this complex cell wall. These two accessory proteins are in a complex with the MmpL3 transporter. One of these proteins, TtfA, is required for mycolic acid transport and cell viability, whereas the other stabilizes the MmpL3 complex. These studies identify two new components of the essential cell envelope biosynthetic machinery in mycobacteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.00850-19

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 MmpL3 and MSMEG_0736 form a complex. (A) Silver-stained SDS-PAGE gel of elutions from GFP-Trap purifications using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP (MGM6425) or MmpL3-msfGFP (MSMEG_0250 [MGM6464]). See Table 1 for protein identifications. (B) Silver-stained SDS-PAGE gel of the first elution from a GFP-Trap purification using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP. The band corresponding to the molecular weight of MmpL3, indicated with an asterisk, was excised and subjected to mass spectrometry analysis and identified as MmpL3 (see Materials and Methods and Table S2 in the supplemental material).
FIG 1 MmpL3 and MSMEG_0736 form a complex. (A) Silver-stained SDS-PAGE gel of elutions from GFP-Trap purifications using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP (MGM6425) or MmpL3-msfGFP (MSMEG_0250 [MGM6464]). See Table 1 for protein identifications. (B) Silver-stained SDS-PAGE gel of the first elution from a GFP-Trap purification using detergent solubilized membranes from M. smegmatis expressing MSMEG_0736-msfGFP. The band corresponding to the molecular weight of MmpL3, indicated with an asterisk, was excised and subjected to mass spectrometry analysis and identified as MmpL3 (see Materials and Methods and Table S2 in the supplemental material).CC BY · PubMed Central
FIG 2 MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation. (A) M. smegmatis strains with deletion of chromosomal ttfA and carrying a copy of ttfA at the attB phage integration site were subjected to marker exchange with attB integrating vectors. Δttfa attB::ttfA strep (MGM6414) strains transformed with pMV306kan (vector), pAJF792 (encoding MsTtfA), or pAJF793 (MtbTtfA) are shown on kanamycin agar. (B) Ten-fold dilutions of M. smegmatis carrying ATc-inducible CRISPRi nontargeting control (NT [MGM6418]) or ttfA (MGM6419) on agar media with and without ATc. (C) Growth curves of nontargeting (MGM6418, blue) and ttfA-targeting (MGM6419, red) CRISPRi M. smegmatis strains grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (D) Growth curves of nontargeting (MGM6715, blue) or three distinct M. tuberculosis ttfA-targeting CRISPRi M. tuberculosis strains (MGM6675, red; MGM6677, green; MGM6679, purple) grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (E) Fluorescence microscopy of an M. smegmatis ttfA-targeting CRISPRi strain marked with MalF(1,2)-mCitrine (MGM6433) 15 h post-CRISPRi induction with ATc (top, −TtfA) or, an uninduced control at 15 h (+TtfA, bottom). YFP (left) and DIC (right) images shown. Exposure times for YFP, 250 ms, 40% LED. (F) Loss of TtfA leads to short cells. Cell lengths of nontargeting (MGM6418, triangles) and TtfA-targeting (MGM6419, circles) CRISPRi strains induced for 12 h. Representative DIC/FM 4-64 images used for quantitation shown above the graph. Error bars are standard deviation and ** indicates P < 0.001.
FIG 2 MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation. (A) M. smegmatis strains with deletion of chromosomal ttfA and carrying a copy of ttfA at the attB phage integration site were subjected to marker exchange with attB integrating vectors. Δttfa attB::ttfA strep (MGM6414) strains transformed with pMV306kan (vector), pAJF792 (encoding MsTtfA), or pAJF793 (MtbTtfA) are shown on kanamycin agar. (B) Ten-fold dilutions of M. smegmatis carrying ATc-inducible CRISPRi nontargeting control (NT [MGM6418]) or ttfA (MGM6419) on agar media with and without ATc. (C) Growth curves of nontargeting (MGM6418, blue) and ttfA-targeting (MGM6419, red) CRISPRi M. smegmatis strains grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (D) Growth curves of nontargeting (MGM6715, blue) or three distinct M. tuberculosis ttfA-targeting CRISPRi M. tuberculosis strains (MGM6675, red; MGM6677, green; MGM6679, purple) grown under uninduced (solid, closed circles) and ATc-induced (dashed, empty circles) conditions. (E) Fluorescence microscopy of an M. smegmatis ttfA-targeting CRISPRi strain marked with MalF(1,2)-mCitrine (MGM6433) 15 h post-CRISPRi induction with ATc (top, −TtfA) or, an uninduced control at 15 h (+TtfA, bottom). YFP (left) and DIC (right) images shown. Exposure times for YFP, 250 ms, 40% LED. (F) Loss of TtfA leads to short cells. Cell lengths of nontargeting (MGM6418, triangles) and TtfA-targeting (MGM6419, circles) CRISPRi strains induced for 12 h. Representative DIC/FM 4-64 images used for quantitation shown above the graph. Error bars are standard deviation and ** indicates P < 0.001.CC BY · PubMed Central
FIG 3 TtfA is a membrane protein that localizes to poles and septa. (A) M. smegmatis TtfA-mCitrine expression strain (MGM6423) imaged during logarithmic growth. YFP (left), DIC (middle), and overlay (right) images shown. Bars, 1 μm. Exposure time for YFP, 1 s, 75% LED. (B) Localization of TtfA-msfGFP by cellular fractionation. Cell-free supernatant and cell pellet fractions (left) and soluble and membrane fractions (right) probed for secreted protein Ag85 (top), membrane protein FtsY (top middle), cytoplasmic protein RpoB (bottom middle), and GFP for TtfA-msfGFP (bottom).
FIG 3 TtfA is a membrane protein that localizes to poles and septa. (A) M. smegmatis TtfA-mCitrine expression strain (MGM6423) imaged during logarithmic growth. YFP (left), DIC (middle), and overlay (right) images shown. Bars, 1 μm. Exposure time for YFP, 1 s, 75% LED. (B) Localization of TtfA-msfGFP by cellular fractionation. Cell-free supernatant and cell pellet fractions (left) and soluble and membrane fractions (right) probed for secreted protein Ag85 (top), membrane protein FtsY (top middle), cytoplasmic protein RpoB (bottom middle), and GFP for TtfA-msfGFP (bottom).CC BY · PubMed Central
FIG 4 TtfA and MmpL3 form a complex in vivo via the essential region of TtfA and independently of TMM synthesis. (A) DDM-solubilized M. smegmatis lysates (left) and GFP-Trap eluates (right) of msfGFP-expressing control (MGM6828) and TtfA-msfGFP (MGM6815) both coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (B) The essential region of MsTtfA is necessary and sufficient for MmpL3 interaction. DDM-solubilized lysates (top) and GFP-Trap eluates (bottom) of msfGFP control (MGM6828), full-length TtfA-msfGFP (1-278 [MGM6829]), or TtfA-msfGFP truncations (1-23 [MGM6826], 1-50 [MGM6823], 1-100 [MGM6827], 1-150 [MGM6824], 1-205 [MGM6822], 24-278 [MGM6825]) coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (C) The MsTtfA-MmpL3 interaction is independent of mycolate synthesis. GFP-Trap eluates of MmpL3-mCherry expression strains coexpressing msfGFP control (MGM6828) or TtfA-msfGFP with either control CRISPRi (NT [MGM6816]) or Pks13 depleted (MGM6817) for 6 h with ATc. Top panel is probed for MmpL3-mCherry with anti-RFP and bottom with anti-GFP.
FIG 4 TtfA and MmpL3 form a complex in vivo via the essential region of TtfA and independently of TMM synthesis. (A) DDM-solubilized M. smegmatis lysates (left) and GFP-Trap eluates (right) of msfGFP-expressing control (MGM6828) and TtfA-msfGFP (MGM6815) both coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (B) The essential region of MsTtfA is necessary and sufficient for MmpL3 interaction. DDM-solubilized lysates (top) and GFP-Trap eluates (bottom) of msfGFP control (MGM6828), full-length TtfA-msfGFP (1-278 [MGM6829]), or TtfA-msfGFP truncations (1-23 [MGM6826], 1-50 [MGM6823], 1-100 [MGM6827], 1-150 [MGM6824], 1-205 [MGM6822], 24-278 [MGM6825]) coexpressing MmpL3-mCherry and probed with anti-RFP (top) and anti-GFP (bottom). (C) The MsTtfA-MmpL3 interaction is independent of mycolate synthesis. GFP-Trap eluates of MmpL3-mCherry expression strains coexpressing msfGFP control (MGM6828) or TtfA-msfGFP with either control CRISPRi (NT [MGM6816]) or Pks13 depleted (MGM6817) for 6 h with ATc. Top panel is probed for MmpL3-mCherry with anti-RFP and bottom with anti-GFP.CC BY · PubMed Central
FIG 5 TtfA and MmpL3 colocalize at cell poles and septa independently of TMM synthesis. (A) Localization of MsTtfA-mCherry/MmpL3-msfGFP (MGM6433, top) and MmpL3-mCherry/TtfA-msfGFP (MGM6434, bottom). (B) Localization of TtfA-msfGFP or MmpL3-msfGFP in Pks13-depleted or mock-depleted cells.
FIG 5 TtfA and MmpL3 colocalize at cell poles and septa independently of TMM synthesis. (A) Localization of MsTtfA-mCherry/MmpL3-msfGFP (MGM6433, top) and MmpL3-mCherry/TtfA-msfGFP (MGM6434, bottom). (B) Localization of TtfA-msfGFP or MmpL3-msfGFP in Pks13-depleted or mock-depleted cells.CC BY · PubMed Central
FIG 6 MsTtfA and MtbTtfA are required for TMM transport. (A) Thin-layer chromatographs (TLCs) of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. smegmatis cultures carrying CRISPRi targeting guide RNAs (nontargeting [MGM6418]; left), ttfA (MGM6419; middle), or mmpL3 (MGM6637; right). Isoniazid treatment served as a positive control for inhibition of all mycolate synthesis. (B) Graph of TDM/TMM ratios for quantitation of TMM and TDM of TLCs in panel A. (C) TLCs of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. tuberculosis cultures depleted for TtfA (MGM6675; left) or MmpL3 (MGM6676; right) (D) Quantitation of TDM/TMM ratios from quantitation of TMM and TDM of TLCs in panel C. ***, P < 0.01.
FIG 6 MsTtfA and MtbTtfA are required for TMM transport. (A) Thin-layer chromatographs (TLCs) of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. smegmatis cultures carrying CRISPRi targeting guide RNAs (nontargeting [MGM6418]; left), ttfA (MGM6419; middle), or mmpL3 (MGM6637; right). Isoniazid treatment served as a positive control for inhibition of all mycolate synthesis. (B) Graph of TDM/TMM ratios for quantitation of TMM and TDM of TLCs in panel A. (C) TLCs of extractable mycolic acids from three replicate 14C-acetic acid-labeled M. tuberculosis cultures depleted for TtfA (MGM6675; left) or MmpL3 (MGM6676; right) (D) Quantitation of TDM/TMM ratios from quantitation of TMM and TDM of TLCs in panel C. ***, P < 0.01.CC BY · PubMed Central
FIG 7 MSMEG_5308-msfGFP accumulates in response to MmpL3 dysfunction. (A) Lysates of MSMEG_5308-msfGFP expression strains with CRISPRi constructs nontargeting control (NT [MGM6766]), MmpL3 (MGM6718), TtfA (MGM6717), or Pks13 (MGM6767) (ATc induction at 0, 2, 4, 6, and 8 hrs) and probed with anti-GFP or anti-RpoB. Anti-GFP blot shown between 75 kDa and 63 kDa as determined by molecular weight marker. (B) Lysates of MSMEG_5308-msfGFP expression strain (MGM6681) treated with dimethyl sulfoxide [DMSO], 10 μg/ml INH, 20 μg/ml INH, 5 μM SQ109, 5 μM BM212, or 5 μM AU1235 for 0, 1.5, or 3 hrs and probed with anti-GFP and anti-RpoB (loading control).
FIG 7 MSMEG_5308-msfGFP accumulates in response to MmpL3 dysfunction. (A) Lysates of MSMEG_5308-msfGFP expression strains with CRISPRi constructs nontargeting control (NT [MGM6766]), MmpL3 (MGM6718), TtfA (MGM6717), or Pks13 (MGM6767) (ATc induction at 0, 2, 4, 6, and 8 hrs) and probed with anti-GFP or anti-RpoB. Anti-GFP blot shown between 75 kDa and 63 kDa as determined by molecular weight marker. (B) Lysates of MSMEG_5308-msfGFP expression strain (MGM6681) treated with dimethyl sulfoxide [DMSO], 10 μg/ml INH, 20 μg/ml INH, 5 μM SQ109, 5 μM BM212, or 5 μM AU1235 for 0, 1.5, or 3 hrs and probed with anti-GFP and anti-RpoB (loading control).CC BY · PubMed Central
FIG 8 MSMEG_5308 localizes to cell poles and septa and stabilizes the TtfA/MmpL3 interaction. (A) MSMEG_5308-msfGFP expression strain (MGM6681) imaged during logarithmic growth. GFP, DIC, and merged images are shown. (B) GFP-Trap pulldown of TtfA-msfGFP/MmpL3-mCherry coexpression strains with nontargeting or MSMEG_5308-targeting CRISPRi constructs. Inputs (left) and eluates (right) from the GFP-Trap column in the presence of either DDM or Triton X-100.
FIG 8 MSMEG_5308 localizes to cell poles and septa and stabilizes the TtfA/MmpL3 interaction. (A) MSMEG_5308-msfGFP expression strain (MGM6681) imaged during logarithmic growth. GFP, DIC, and merged images are shown. (B) GFP-Trap pulldown of TtfA-msfGFP/MmpL3-mCherry coexpression strains with nontargeting or MSMEG_5308-targeting CRISPRi constructs. Inputs (left) and eluates (right) from the GFP-Trap column in the presence of either DDM or Triton X-100.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 66

Metadata

Authors
Fay, A., Czudnochowski, N., Rock, J. M., Johnson, J. R., Krogan, N. J., Rosenberg, O., & Glickman, M. S.
Affiliations
  • Immunology Program, Sloan Kettering Institute, New York, New York, USA
  • University of California, San Francisco (US)
  • Rockefeller University (US)
  • Gladstone Institutes (US)
  • Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Glickman, Michael S.
Venue
mBio
Published
2019-06-25
Volume
10
Issue
3
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2954810968
Cited by
65
References
65
Citations by year
2026: 7 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 3 · 2021: 8 · 2020: 10 · 2019: 5
FWCI
4.98
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • HHS | NIH | National Cancer Institute (P30 CA008748)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (U19-111143, R01 AI120694, P01 AI063302, 1U19AI135990, 5R01AI128214, P01AI095208)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
Mycobacterium tuberculosis, accessory proteins, cell envelope biosynthesis, mycobacterial cell wall, protein complex stabilization, cell viability
MeSH terms
Bacterial Proteins, Cell Membrane, Cell Wall, Mycobacterium tuberculosis, Mycolic Acids, Mycobacterium smegmatis, Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria. https://app.cochat.ai/papers/10.1128/mbio.00850-19
The paper
Fay, A., Czudnochowski, N., Rock, J. M., Johnson, J. R., Krogan, N. J., Rosenberg, O., & Glickman, M. S. (2019). Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria. mBio. https://doi.org/10.1128/mbio.00850-19

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.